Sanofi Pasteur Announces FDA Approval Of Fluzone Intradermal Quadrivalent

SWIFTWATER, Pa., Dec. 12, 2014 /PRNewswire/ — Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental biologics license… – New Drug Approvals

Pharmaceutical Stocks


© 2018 Drugs News All rights reserved.       Privacy Policy       Contact Us